Innoviva
INVA
#5200
Rank
A$2.26 B
Marketcap
A$30.23
Share price
4.90%
Change (1 day)
0.88%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): A$0.23 Billion

According to Innoviva's latest financial reports the company's current earnings are A$0.38 Billion. In 2024 the company made an earning of A$53.86 Million a decrease over its 2023 earnings that were of A$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.23 B338.49%
2024 A$53.86 M-80.74%
2023 A$0.27 B-32.36%
2022 A$0.41 B-35.56%
2021 A$0.64 B25.7%
2020 A$0.51 B52.11%
2019 A$0.33 B10.77%
2018 A$0.30 B56.59%
2017 A$0.19 B125.53%
2016 A$85.77 M-417.36%
2015 -A$27.03 Million-74.49%
2014 -A$0.11 Billion-25.19%
2013 -A$0.15 Billion430.06%
2012 -A$26.72 Million-83.92%
2011 -A$0.17 Billion39.82%
2010 -A$0.12 Billion2.84%
2009 -A$0.12 Billion-8.62%
2008 -A$0.13 Billion-47.92%
2007 -A$0.25 Billion-5.92%
2006 -A$0.26 Billion19.8%
2005 -A$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.16 Million-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA